Camylofin


Generic Medicine Info
Indications and Dosage
Parenteral
Intestinal colic, Biliary colic, Renal colic, Dysmenorrhoea
Adult: 1mL (25 mg) by IM or IV Inj up to a max of tid.
Contraindications
Narrow-angle glaucoma, prostatic hypertrophy, mechanical stenoses.
Special Precautions
Camylofin Inj must be administered with care in thyrotoxicosis, obstructive airway disease, during cardiac surgery, elderly or those with fever.
Adverse Reactions
Injection may cause skin rashes, other allergic reactions and infrequently atropine-like side effects.
Drug Interactions
Camylofin Inj should be co-administered with caution in patients taking amantadine, quinidine and tricyclic antidepressants.
Action
Description:
Mechanism of Action: Camylofin is a smooth muscle relaxant with both anticholinergic action as well as direct smooth muscle action. Anticholinergic action is produced by inhibiting the binding of acetylcholine to muscarinic receptors, but the action is less pronounced. Direct smooth muscle relaxation is achieved by inhibiting phosphodiesterase type IV, which leads to increased cyclic AMP and eventually reduced cytosolic calcium. Thus camylofin has a comprehensive action to relieve smooth muscle spasm.
MIMS Class
Antispasmodics
Disclaimer: This information is independently developed by MIMS based on Camylofin from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in